Related Experiment Video

Updated: May 7, 2026

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells
09:32

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells

Published on: February 27, 2020

Role of STAT1 in the breast

Sarah G Bailey1, Mark S Cragg, Paul A Townsend

  • 1Cancer Sciences Unit; Cancer Research UK Centre; Faculty of Medicine; University of Southampton; Southampton General Hospital; Southampton, UK.

JAK-STAT
|September 24, 2013
PubMed

Insights

Signal transducer and activator of transcription-1 (STAT1) is crucial for cellular responses. Recent findings highlight STAT1

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Signal transducer and activator of transcription-1 (STAT1) mediates cellular responses to stress, cytokines, and DNA damage.
  • STAT1's function as a pro- or anti-apoptotic factor is context-dependent, regulated by post-translational modifications.
  • Loss of STAT1 in breast tissue impacts cancer development and treatment response.

Purpose of the Study:

  • To discuss recent findings on the role of STAT1 in breast cancer.
  • To highlight a newly identified function of STAT1 in specific breast cancer subtypes.

Main Methods:

  • Review of recent research findings, including those by Chan et al. in Breast Cancer Research.
  • Analysis of STAT1's role in the context of estrogen receptor (ER)-positive and progesterone receptor (PR)-positive breast cancers.

Main Results:

  • STAT1 plays a significant role in the development of breast cancers.
  • Loss of STAT1 influences both tumor development and response to therapy.
  • STAT1 has a newly described role in ER-positive and PR-positive luminal breast cancers.

Conclusions:

  • STAT1 is implicated in the pathogenesis of luminal breast cancers.
  • Understanding STAT1's function is critical for developing targeted breast cancer therapies.
Keywords:
STAT1breast cancerimmunitymousetranscription

More Related Videos

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...